cytisine derivatives (Pfizer)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namecytisine derivatives (Pfizer)
Drug Alias Nameanti-smoking therapy (Pfizer)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNicotinic receptors modulators
TargetsNicotinic receptors
Therapy Area/IndicationsTobacco Use Disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsTobacco Use Disorder

Other Information

ATC CodeN/A
Related LinksN/A